Average Co-Inventor Count = 2.45
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Université´ D'aix-Marseille (7 from 232 patents)
2. Institut National De La Sante Et De La Recherche Medicale (5 from 1,748 patents)
3. Institut Jean Paoli & Irène Calmettes (5 from 26 patents)
4. Centre National De La Recherche Scientifique (3 from 5,104 patents)
5. Centre National De La Recherche Scientifique-Cnrs (2 from 75 patents)
6. Inserm (Institut National De La Sante Et De La Recherche Medicale) (2 from 49 patents)
7. Other (1 from 832,966 patents)
8. Eli Lilly and Company (1 from 4,450 patents)
9. Universite Claude Bernard – Lyon1 (1 from 215 patents)
10. Centre Nationale De La Recherche Scientifique (1 from 21 patents)
11. L'institut Paoli-Calmettes (1 from 1 patent)
12. Mablink Bioscience (1 from 1 patent)
13. Institut Jean Paoli & Irene Calettes (1 from 1 patent)
14. Emergence Therapeutics Gmbh (1 from 1 patent)
15. Inserm (0 patent)
8 patents:
1. 12419964 - Antibody drug conjugate (ADC) targeting Nectin 4 and comprising an exatecan payload
2. 12398206 - Antibodies having specificity for nectin-4 and uses thereof
3. 12049500 - Anti-nectin-4-antibodies and uses thereof
4. 11274160 - Antibodies having specificity to Nectin-4 and uses thereof
5. 10675357 - Antibodies having specificity to nectin-4 and uses thereof
6. 9266922 - Antigen peptide and uses thereof
7. 9193699 - Apoptosis inducing compounds
8. 6469155 - HIgR and related domain which binds glycoprotein D of herpes simplex virus